重大事件
即時報告
8-K
2026-06-10
根據Item 5.02，公司披露了有關董事或特定高管的離職、選舉或任命，以及相關補償安排的變動。具體人事調整詳情已在文件中載明。
AI 繁中摘要
📋 Metagenomi Therapeutics, Inc.（一家生物製品公司）於2026年6月9日向SEC提交了一份8-K表格，報告兩項主要事項。
👥 根據Item 5.02，公司披露了有關董事或特定高管的離職、選舉或任命，以及相關補償安排的變動。具體人事調整詳情已在文件中載明。
🗳️ 根據Item 5.07，公司報告了股東投票事項的結果。相關提案及表決情況均按規定進行了披露。
由於本次申報屬事件披露性質，並未涉及具體財務業績數字或管理層展望。對投資者而言，高層人事變動及股東投票結果可能影響公司未來治理方向及決策效率，建議投資者細閱完整文件以評估潛在影響。
展開英文正文
EDGAR Filing Documents for 0001193125-26-264392 SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001193125-26-264392 Filing Date 2026-06-10 Accepted 2026-06-09 18:11:53 Documents 9 Period of Report 2026-06-09 Items Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.07: Submission of Matters to a Vote of Security Holders Interactive Data Document Format Files Seq Description Document Type Size 1 8-K mgx-20260609.htm iXBRL 8-K 58596 Complete submission text file 0001193125-26-264392.txt 168921 Data Files Seq Description Document Type Size 2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mgx-20260609.xsd EX-101.SCH 25806 12 EXTRACTED XBRL INSTANCE DOCUMENT mgx-20260609_htm.xml XML 4893 Mailing Address 5959 HORTON STREET 7TH FLOOR EMERYVILLE CA 94608 Business Address 5959 HORTON STREET 7TH FLOOR EMERYVILLE CA 94608 (510) 871-4880 Metagenomi Therapeutics, Inc. (Filer) CIK: 0001785279 (see all company filings) EIN.: 813909017 | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-41949 | Film No.: 261077399 SIC: 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)